Decitabine activates type I interferon signaling to inhibit p53-deficient myeloid malignant cells.

ABSTRACT:

SUBMITTER: Wu J 

PROVIDER: S-EPMC8571953 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature